or Try an Advanced Search...

    Technical Analysis for DRUG - Bright Minds Biosciences Inc.

    Grade Last Price % Change Price Change
    F 1.10 -2.31% -0.03
    DRUG closed down 2.31 percent on Friday, May 24, 2024, on 14 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical DRUG trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Gapped Down Weakness 0.00%
    NR7 Range Contraction -2.31%
    Fell Below 50 DMA Bearish -2.43%
    Inside Day Range Contraction -2.43%
    Upper Bollinger Band Touch Strength -2.43%
    Gapped Down Weakness -2.43%
    Older End-of-Day Signals for DRUG ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 4 days ago
    10 DMA Resistance 4 days ago
    10 DMA Support 4 days ago
    Up 1% 4 days ago
    Fell Below Previous Day's Low 4 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    DRUG Chart by TradingView
    Basic chart:

    Profile

    Bright Minds Biosciences Inc., a pre-clinical biosciences company, develops 5-HT (serotonin) medicines to improve the lives of patients with severe and life-altering diseases. Its portfolio of selective 5-HT receptor agonists comprises 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry. The company has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was incorporated in 2019 and is headquartered in Vancouver, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Drugs Pain Organic Compounds Chemical Compounds Epilepsy Antidepressants Neurotransmitters Treatment Of Epilepsy

    Is DRUG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 7 Mind Medicine sends psychedelic stocks higher after FDA status for LSD formulation
    Jan 27 Psyched: Suggestibility And Psychedelics' Effects, EU's $7M Research Fund, Australia's Treatment Delivery, BZ Podcast And More
    Jan 12 Psyched: $100M For MDMA Therapy, VA Funds, 2024 Watchlist, Reform Updates And More
    Jan 7 Psyched: Ibogaine For TBI, Kentucky Initiative Stalled, DEA Quotas, Insurance Codes, Atai's $50M And More
    Dec 11 Psyched: John Lennon Remembered, Clinical Trials For Service Members, Chrissy Teigen, Jon Feliciano And More
    Dec 6 Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management
    See more DRUG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.44
    52 Week Low 0.93
    Average Volume 18,510
    200-Day Moving Average 1.59
    50-Day Moving Average 1.16
    20-Day Moving Average 1.08
    10-Day Moving Average 1.11
    Average True Range 0.09
    RSI (14) 47.64
    ADX 21.23
    +DI 16.46
    -DI 12.95
    Chandelier Exit (Long, 3 ATRs) 0.97
    Chandelier Exit (Short, 3 ATRs) 1.20
    Upper Bollinger Bands 1.19
    Lower Bollinger Band 0.97
    Percent B (%b) 0.61
    BandWidth 19.76
    MACD Line -0.01
    MACD Signal Line -0.03
    MACD Histogram 0.0162
    Fundamentals Value
    Market Cap 4.92 Million
    Num Shares 4.46 Million
    EPS -1.47
    Price-to-Earnings (P/E) Ratio -0.75
    Price-to-Sales 0.00
    Price-to-Book 1.73
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.17
    Resistance 3 (R3) 1.18 1.16 1.16
    Resistance 2 (R2) 1.16 1.14 1.16 1.15
    Resistance 1 (R1) 1.13 1.13 1.15 1.13 1.15
    Pivot Point 1.12 1.12 1.12 1.11 1.12
    Support 1 (S1) 1.09 1.10 1.10 1.08 1.05
    Support 2 (S2) 1.07 1.09 1.07 1.05
    Support 3 (S3) 1.04 1.07 1.05
    Support 4 (S4) 1.04